Cardiometabolic disease prediction, causal analysis and drug development using high-resolution 1 H- nuclear magnetic resonance (NMR) metabolomics (The UCLEB consortium)

Project Details

Effective start/end date1/01/1430/06/17


  • Other: £41,556.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
  • Mendelian randomization of blood lipids for coronary heart disease

    on behalf of the UCLEB consortium, Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., Tragante, V., van Iperen, E. P. A., Sivapalaratnam, S., Shah, S., Elbers, C. C., Shah, T., Engmann, J., Giambartolomei, C., White, J., & 31 othersZabaneh, D., Sofat, R., McLachlan, S., Doevendans, P. A., Balmforth, A. J., Hall, A. S., North, K. E., Almoguera, B., Hoogeveen, R. C., Cushman, M., Fornage, M., Patel, S. R., Redline, S., Siscovick, D. S., Tsai, M. Y., Karczewski, K. J., Hofker, M. H., Verschuren, W. M., Bots, M. L., van der Schouw, Y. T., Melander, O., Dominiczak, A. F., Morris, R., Ben-Shlomo, Y., Price, J., Kumari, M., Baumert, J., Peters, A., Thorand, B., Koenig, W. & Gaunt, T. R., 27 Jan 2014, In: European Heart Journal.

    Research output: Contribution to journalArticlepeer-review

    Open Access